Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Gestoden Ethinylestradiol Stada 30" (43)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Gestodene and Ethinylestradiol (G03AA10) 43 products
WHO-DDD
DrugBank.ca
IP
CI
Gestoden Ethinylestradiol
Stada 20
21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gestoden Ethinylestradiol
Stada 20
3 x 21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gestoden Ethinylestradiol
Stada 20
6 x 21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gestoden Ethinylestradiol
Stada 30
21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gestoden Ethinylestradiol
Stada 30
3 x 21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gestoden Ethinylestradiol
Stada 30
6 x 21
PR
PR
k.A.
Dragées: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 20
21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 20
3 x 21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 20
6 x 21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
3 x 21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
6 x 21
PR
PR
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Estinette 20
21 Dragée(s)
PR
14.70
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 20
3 x 21 Dragée(s)
PR
38.95
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 20
6 x 21 Dragée(s)
PR
62.30
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
21 Dragée(s)
PR
14.70
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
3 x 21 Dragée(s)
PR
38.95
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
6 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
21 Dragée(s)
PR
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
3 x 21 Dragée(s)
PR
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
6 x 21 Dragée(s)
PR
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
21 Dragée(s)
PR
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
3 x 21 Dragée(s)
PR
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
6 x 21 Dragée(s)
PR
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Meliane 21
‐
I
21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Meliane 21
3 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Meliane 21
6 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
3 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
6 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Gyselle petite 28
28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Gyselle petite 28
3 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Minesse
28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Minesse
3 x 28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Minesse
6 x 28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Pfizer AG
●
B
FB
G
IP
CI
Mirelle
28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Mirelle
3 x 28 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Harmonet
21 Dragée(s)
PR
19.90
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
IP
CI
Harmonet
3 x 21 Dragée(s)
PR
57.65
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
IP
CI
Harmonet
6 x 21 Dragée(s)
PR
110.75
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
IP
CI
Minulet
‐
I
21 Dragée(s)
PR
18.85
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
IP
CI
Minulet
3 x 21 Dragée(s)
PR
53.65
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
IP
CI
Minulet
6 x 21 Dragée(s)
PR
106.05
k.A.
überzogene Tabletten: 2 Active Agents
Pfizer AG
B / LPPV
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
